GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis

OSL:GENT • NO0010748866

38.9 NOK
-0.6 (-1.52%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year GENT was profitable.
  • GENT had a positive operating cash flow in the past year.
  • GENT had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • The Return On Assets of GENT (18.38%) is better than 96.83% of its industry peers.
  • The Return On Equity of GENT (21.18%) is better than 90.48% of its industry peers.
  • The Return On Invested Capital of GENT (8.76%) is better than 73.02% of its industry peers.
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROIC 8.76%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • GENT's Profit Margin of 24.80% is amongst the best of the industry. GENT outperforms 95.24% of its industry peers.
  • GENT has a Operating Margin of 13.44%. This is in the better half of the industry: GENT outperforms 60.32% of its industry peers.
  • The Gross Margin of GENT (55.06%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of GENT has declined.
Industry RankSector Rank
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GENT is creating some value.
  • Compared to 1 year ago, GENT has about the same amount of shares outstanding.
  • Compared to 5 years ago, GENT has about the same amount of shares outstanding.
  • Compared to 1 year ago, GENT has an improved debt to assets ratio.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • GENT has an Altman-Z score of 12.84. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
  • GENT has a Altman-Z score of 12.84. This is amongst the best in the industry. GENT outperforms 95.24% of its industry peers.
  • The Debt to FCF ratio of GENT is 0.59, which is an excellent value as it means it would take GENT, only 0.59 years of fcf income to pay off all of its debts.
  • GENT has a better Debt to FCF ratio (0.59) than 95.24% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.01, GENT belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Altman-Z 12.84
ROIC/WACC1.03
WACC8.48%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT has a better Current ratio (5.98) than 98.41% of its industry peers.
  • GENT has a Quick Ratio of 4.16. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.16, GENT belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 4.16
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 2066.40% over the past year.
  • Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 17.42% in the last year.
  • Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%

3.2 Future

  • GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
  • Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 20.47% on average per year.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.25 indicates a correct valuation of GENT.
  • Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a rather cheap valuation: GENT is cheaper than 95.24% of the companies listed in the same industry.
  • GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.34, GENT is valued correctly.
  • 79.37% of the companies in the same industry are more expensive than GENT, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, GENT is valued a bit cheaper.
Industry RankSector Rank
PE 14.25
Fwd PE 14.34
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GENT indicates a slightly more expensive valuation: GENT is more expensive than 63.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 184.62
EV/EBITDA 15.99
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.49%, GENT has a reasonable but not impressive dividend return.
  • In the last 3 months the price of GENT has falen by -29.01%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.06, GENT pays a bit more dividend than its industry peers.
  • GENT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.49%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

GENTIAN DIAGNOSTICS ASA

OSL:GENT (3/2/2026, 7:00:00 PM)

38.9

-0.6 (-1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners2.6%
Ins Owner ChangeN/A
Market Cap599.84M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target64.26 (65.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.59%
Revenue NY rev (3m)-8.59%
Valuation
Industry RankSector Rank
PE 14.25
Fwd PE 14.34
P/S 3.48
P/FCF 184.62
P/OCF 48.37
P/B 2.97
P/tB 3.53
EV/EBITDA 15.99
EPS(TTM)2.73
EY7.02%
EPS(NY)2.71
Fwd EY6.97%
FCF(TTM)0.21
FCFY0.54%
OCF(TTM)0.8
OCFY2.07%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.24
PEG (5Y)N/A
Graham Number28.37
Profitability
Industry RankSector Rank
ROA 18.38%
ROE 21.18%
ROCE 11.37%
ROIC 8.76%
ROICexc 15.22%
ROICexgc 21.01%
OM 13.44%
PM (TTM) 24.8%
GM 55.06%
FCFM 1.88%
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.59
Debt/EBITDA 0.06
Cap/Depr 101.32%
Cap/Sales 5.3%
Interest Coverage 250
Cash Conversion 38.48%
Profit Quality 7.6%
Current Ratio 5.98
Quick Ratio 4.16
Altman-Z 12.84
F-Score5
WACC8.48%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year169.23%
EBIT Next 3Y84.01%
EBIT Next 5Y65.28%
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


How financially healthy is GENTIAN DIAGNOSTICS ASA?

The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.